Genetic Technologies Operating Margin 2010-2022 | GENE
Current and historical operating margin for Genetic Technologies (GENE) over the last 10 years. The current operating profit margin for Genetic Technologies as of December 31, 2022 is 0.00%.
|Genetic Technologies Operating Margin Historical Data
||TTM Operating Income
||Medical - Biomedical and Genetics
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.